药明生物(02269)根据首次公开发售前购股权计划发行合计150.2万股

Core Viewpoint - WuXi Biologics (02269) announced the issuance of a total of 1.502 million ordinary shares as part of the exercise of options under its pre-IPO share option plan adopted on January 5, 2016, and revised on August 10, 2016 [1] Summary by Category - Company Actions - The company has issued 1.502 million ordinary shares as a result of exercising options under its share option plan [1]